Bozomitu Laura, Moraru Evelina, Stana B, Burlea M, Aprodu G, Moraru D
Clinica a V(-a) Pediatrie, Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi Facultatea de Medicină.
Rev Med Chir Soc Med Nat Iasi. 2010 Jul-Sep;114(3):625-32.
The hepato-pulmonary syndrome (HPS) is a rare complication of liver cirrhosis, with poor outcome; the term includes liver disease, increased alveolo-arterial gradient and intrapulmonary vascular dilations, described by Fluckiger, Kennedy and Knudson. HPS impairs survival in cirrhotic patients and the posttransplant outcome is altered in correlation with severity of HPS. Combined determination of SaO2 in clino- and orthostatic position by a pulsoximeter is a simple test for HPS identification in patients with chronic liver disease or non-cirrhotic portal hypertension.
肝肺综合征(HPS)是肝硬化的一种罕见并发症,预后较差;该术语包括肝脏疾病、肺泡-动脉氧分压差增加和肺内血管扩张,由弗卢基格、肯尼迪和克努森描述。HPS会损害肝硬化患者的生存率,移植后的预后会因HPS的严重程度而改变。通过脉搏血氧仪联合测定患者卧位和立位时的血氧饱和度(SaO2),是一种用于识别慢性肝病或非肝硬化门静脉高压患者是否患有HPS的简单检测方法。